Special Issue "Antioxidant Supplementation on Fertility"

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: 20 July 2023 | Viewed by 2675

Special Issue Editors

Associate Professor, Department of Urology, Aristotle University School of Medicine, Thessaloniki, Greece
Interests: male infertility; oxidative stress; antioxidant defenses; antioxidant supplementation; redox mechanisms of drugs; reactive oxygen species (ROS); lipid peroxidation; reactive nitrogen species (RNS); varicocele; microsurgical operations in andrology
Professor, Department of Urology, School of Medicine, Ioannina University, 45500 Ioannina, Greece
Interests: male infertility; varicocele; microsurgical operations in andrology

Special Issue Information

Dear Colleagues,

Couples’ subfertility may be attributable to male factors, female factors, or a combination of both. However, no etiological factors have been detected in the infertile couples subpopulation. These couples are characterized as having idiopathic infertility. It is has been proposed that oxidative stress (OS) is involved in the pathophysiology of subfertility, and antioxidants are thought to reduce the detrimental consequences of OS, which are manifested both in the standard parameters of analysis and in the outcome of sperm functional assays in subfertile couples. Moreover, OS has been implicated in several placental disorders and pregnancy pathologies. Systemic disorders and conditions leading to infection and inflammation are commonly attributed to enhanced OS; thus, the discovery of inflammatory markers and treatment modalities will have major clinical implications for male infertility. Diet might also affect couples’ reproductive potential, although the involved biochemical mechanisms remain poorly elucidated. In the last decade, the consumption of organic food has increased worldwide, with consumers hoping to reduce the risk of developing chronic diseases despite the scarce scientific evidence supporting this phenomenon. In addition, available knockout animal models might help us to better understand the role of different antioxidant enzymes in male reproductive capacity, and the development of novel animal models lacking different antioxidants is crucial to understanding the consequences of high ROS levels in the human reproductive chain.

Oocytes have only a limited capacity to repair sperm-derived decays, and therefore reducing sperm DNA damage linked to OS represents a promising approach. For example, a detailed analysis of DNA fragmentation or lack of nuclear condensation is mandatory prior to any treatment. Antioxidants represent readily available and inexpensive pharmaceutical compounds. On the other hand, there is a lack of high-quality evidence demonstrating antioxidant administration’s effect on infertile couples, whether beneficial or detrimental. Instead, antioxidant supplements with ambiguous efficiency and potentially detrimental effects are often given arbitrarily. For that reason, oxidation reduction has emerged as a viable ancillary tool for basic semen analysis, measuring the overall balance between oxidative and reductive stress.

This Special Issue is open to all investigations exploring antioxidant supplementation for fertility and providing preliminary findings with potential for clinical translation. Topics of interest include, but are not limited to:

  • Effect of antioxidant supplementation on male fertility;
  • Effect of antioxidants on sperm genetic damage and sperm energetic metabolism;
  • Effect of antioxidant supplementation on female fertility;
  • Oxidative stress in pregnancy and fertility pathologies;
  • Effect of antioxidant supplementation on conventional and advanced sperm function tests;
  • The role of infection and inflammation-mediated OS in fertility;
  • Investigation of antioxidant enzymes and male fertility through knockout animal models;
  • Diet and its impact on fertility.

We look forward to receiving your contributions.

Dr. Fotios Dimitriadis
Prof. Dr. Nikolaos Sofikitis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oxidative stress
  • antioxidants
  • couple subfertility
  • OS-mediated sperm genetic damage
  • OS and conventional or advanced sperm function tests
  • infection and inflammation-mediated OS

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

Article
CYP19A1 TC/CC Polymorphism, along with Deletion of GSTM1 and GSTT1 Genes, Strongly Influences Female Infertility Risk
Antioxidants 2023, 12(4), 940; https://doi.org/10.3390/antiox12040940 - 16 Apr 2023
Viewed by 685
Abstract
Oxidative stress has a fundamental role in the pathophysiology of various conditions, like infertility. This case-control study was performed to assess the potential role of CYP19A1, GSTM1, and GSTT1 in modifying individual predisposition to female infertility. Genotyping of 201 women with [...] Read more.
Oxidative stress has a fundamental role in the pathophysiology of various conditions, like infertility. This case-control study was performed to assess the potential role of CYP19A1, GSTM1, and GSTT1 in modifying individual predisposition to female infertility. Genotyping of 201 women with established infertility and 161 fertile female controls was performed, and statistical associations were analyzed. For carriers of GSTM1 null genotype along with CYP19A1 C allele, there is a significant association with female infertility risk (OR 7.023; 95% CI (3.627–13.601; p < 0.001), and, also for carriers of GSTT1 null genotype along with the CYP19A1 TC/CC genotype (OR 24.150; 95% CI (11.148–52.317; p < 0.001). A positive association with female infertility risk for carriers of the C allele in CYP19A1 and null genotypes in GTSM1 (OR 11.979; 95% CI (4.570–31.400; p < 0.001) or GSTT1 (OR 13.169; 95% CI (4.518–38.380; p < 0.001) was found. When both GSTs are deleted, the risk of developing female infertility is significant, independently of the CYP19A1 genotype; when all the presumed high-risk genotypes are present, we found a significant association with female infertility risk (OR 47,914; 95% CI (14,051–163,393; p < 0.001). Full article
(This article belongs to the Special Issue Antioxidant Supplementation on Fertility)
Show Figures

Figure 1

Review

Jump to: Research, Other

Review
The Role of Seminal Oxidative Stress in Recurrent Pregnancy Loss
Antioxidants 2023, 12(3), 723; https://doi.org/10.3390/antiox12030723 - 15 Mar 2023
Viewed by 585
Abstract
Recurrent pregnancy loss is a distressing condition affecting 1–2% of couples. Traditionally investigations have focused on the female, however more recently researchers have started to explore the potential contribution of the male partner. Seminal reactive oxygen species have a physiological function in male [...] Read more.
Recurrent pregnancy loss is a distressing condition affecting 1–2% of couples. Traditionally investigations have focused on the female, however more recently researchers have started to explore the potential contribution of the male partner. Seminal reactive oxygen species have a physiological function in male reproduction but in excess are suspected to generate structural and functional damage to the sperm. Evidence is mounting to support an association between elevated seminal reaction oxygen species and recurrent pregnancy loss. Studies suggest that the rates of sperm DNA damage are higher in the male partners of women affected by recurrent pregnancy loss compared with unaffected men. However, the available pool of data is conflicting, and interpretation is limited by the recent change in nomenclature and the heterogeneity of study methodologies. Furthermore, investigation into the effects of oxidative stress on the epigenome show promise. The value of antioxidant therapy in the management of recurrent pregnancy loss currently remains unclear. Full article
(This article belongs to the Special Issue Antioxidant Supplementation on Fertility)
Show Figures

Figure 1

Other

Jump to: Research, Review

Systematic Review
Antioxidant Supplementation on Male Fertility—A Systematic Review
Antioxidants 2023, 12(4), 836; https://doi.org/10.3390/antiox12040836 - 30 Mar 2023
Viewed by 983
Abstract
Our aim was to review the current literature regarding the effect of antioxidant supplementation (AS) on male fertility parameters, as AS is commonly used to treat male infertility due to the availability and affordability of antioxidants in many parts of the world. Materials [...] Read more.
Our aim was to review the current literature regarding the effect of antioxidant supplementation (AS) on male fertility parameters, as AS is commonly used to treat male infertility due to the availability and affordability of antioxidants in many parts of the world. Materials and methods: PubMed, Medline, and Cochrane electronic bibliographies were searched using the modified Preferred Reporting Items for Systemic Reviews and Meta-Analyses (PRISMA) guidelines to evaluate studies on the benefit of antioxidant therapy on infertile men. Results were analyzed regarding the following aspects: (a) ingredient and dose; (b) potential mechanism of action and rationale for use; and (c) effect on various reported outcomes. Results: Thus, 29 studies found a substantial positive effect of AS on outcomes of assisted reproductive therapy (ART), WHO semen parameters, and live-birth rate. Carnitines, Vitamin E and C, N-acetyl cysteine, coenzyme Q10, selenium, zinc, folic acid, and lycopene were beneficial ingredients. Nevertheless, some studies did not show a substantial change in one or more factors. Conclusion: AS seems to have a positive effect on male fertility. Environmental factors may play an increasing role in fertility. Further studies are needed to determine the optimal AS combination and the influence of environmental factors. Full article
(This article belongs to the Special Issue Antioxidant Supplementation on Fertility)
Show Figures

Figure 1

Back to TopTop